
Bioorganic and Medicinal Chemistry Letters p. 1767 - 1770 (1998)
Update date:2022-07-30
Topics:
Mogensen, John P.
Roberts, Stanley M.
Bowler, Andrew N.
Thomsen, Christian
Knutsen, Lars J. S.
The synthesis and purinergic receptor binding of novel adenosine A3 ligands is described. Many selective A3 receptor agonists e.g. N-(3- iodobenzyl)adenosine-5'-methyluronamide (IB-MECA) contain a 4'- ribosylalkylamide moiety. We found that this amide and other 4'-functional groups could be replaced with an isosteric isoxazole, and the target molecules retained potent binding to the recombinant human A3 receptor.
View MoreContact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:--
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Contact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Doi:10.1016/S0968-0896(03)00401-2
(2003)Doi:10.1021/om980151z
(1998)Doi:10.3987/COM-05-S(T)74
(2006)Doi:10.1016/S0040-4039(97)00410-3
(1997)Doi:10.1016/S0957-4166(98)00282-1
(1998)Doi:10.1016/S0040-4020(98)83036-6
(1998)